Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides-Reference-Cited by-同舟云学术

Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides

Published:2014-08-11 Issue:7 Volume:40 Page:804-810
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Patwardhan V. R.¹,Sengupta N.¹,Bonder A.¹,Lau D.¹,Afdhal N. H.¹

Affiliation:

1. Division of Gastroenterology; Beth Israel Deaconess Medical Center; Boston MA USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12908/fullpdf

Reference40 articles.

1. Hepatitis B e antigen-negative chronic hepatitis B;Hadziyannis;Hepatology,2001

2. Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment;Hadziyannis;Semin Liver Dis,2006

3. “e” antigen defective hepatitis B virus and course of chronic infection;Brunetto;J Hepatol,1991

4. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study;Brunetto;J Hepatol,2002

5. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Hepatitis B Surface Antigen Profile and Seroclearance Following Antiviral Treatment: A Single-Center, Real-World Cohort Study;Biomedicines;2023-11-03

2. Predictive Value of HBsAg for Off-treatment Response in HBeAg-negative Chronic Hepatitis B Patients;Journal of the College of Physicians and Surgeons Pakistan;2023-01-01

3. Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients;Hepatology Research;2022-02-21

4. Challenges in the discontinuation of chronic hepatitis B antiviral agents;World Journal of Hepatology;2021-09-27

5. Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis;Gut;2021-09-07